Latest News
Zealand Pharma's Zeydovio (glepaglutide) receives positive CHMP opinion for short bowel syndrome treatment
21 September 2026 - Danish biotechnology company Zealand Pharma A/S (Nasdaq: ZEAL) announced on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending ma...
Velocity Clinical Research appoints new CEO
21 September 2026 - Clinical research site organisation Velocity Clinical Research announced on Friday the appointment of Justin Starzyk as chief executive officer.Paul Evans, PhD, will continue as chair of the board to support the company's gro...
Ocular Therapeutix reports inducement equity awards granted to nine new employees
21 September 2026 - Ocular Therapeutix Inc (NASDAQ:OCUL), an integrated biopharmaceutical company focused on retinal disease, said on Friday that it has granted inducement equity awards to nine newly hired non-executive employees.The awards were made...
Ipsen appoints new board director
21 September 2026 - French biopharmaceutical company Ipsen (Euronext Paris:IPN) (ADR:IPSEY) announced on Friday the appointment of Mariette Finet as a director to its board of directors, effective immediately.Finet succeeds Michele Ollier, who resign...
Coiled Therapeutics completes enrolment in two AO-252 formulation cohorts
21 September 2026 - Oncology company Coiled Therapeutics plc (AIM: COIL) (OTCQB: COTXF) declared on Monday that it has completed enrollment across two cohorts evaluating its new lipid-based softgel formulation of AO-252, enrolling three patients each...